Metropolitan Life Insurance Company (MetLife)’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-523
Closed -$6.64K 2460
2023
Q1
$6.64K Buy
+523
New +$6.64K ﹤0.01% 2257